- Update on settlement
- Holding(s) in Company - Replacement
- Holding(s) in Company
- New shares registered with Finnish Trade Register
- Fully subscribed EUR 30.7 million share offering
- Proposed REX Retail Offer
- Faron commences a share offering
- Initial positive data from Phase 2 of BEXMAB
- Issuance of warrants
- Founders named European Inventor Award finalists
More ▼
Key statistics
On Friday, Faron Pharmaceuticals Oy (FARN:LSE) closed at 94.00, 10.59% above the 52 week low of 85.00 set on Jun 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 94.00 |
---|---|
High | 89.00 |
Low | 89.00 |
Bid | 91.00 |
Offer | 98.00 |
Previous close | 94.00 |
Average volume | 28.86k |
---|---|
Shares outstanding | 104.62m |
Free float | 71.27m |
P/E (TTM) | -- |
Market cap | 98.19m GBP |
EPS (TTM) | -0.2815 GBP |
Data delayed at least 20 minutes, as of Jul 05 2024 14:19 BST.
More ▼